Article

The pan-cancer analysis uncovers the prognostic and immunotherapeutic significance of CD19 as an immune marker in tumor

2023-08-03

Abstract excerpt

The specific cytotoxic effects of anti-CD19 chimeric antigen receptor (CAR) T-cell therapy have led to impressive outcomes in individuals previously treated for B-cell malignancies. However, the specific biological role of CD19(+) target cells, which exert antitumor immunity against some solid tumors, remains to be elucidated. We collected information regarding the level of CD19 mRNA and protein expression from va...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1fe4419e-b0ba-52ba-ae2a-8fbfd70c36df
DOI: 10.21203/rs.3.rs-3212266/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The pan-cancer analysis uncovers the prognostic and immunotherapeutic significance of CD19 as an immune marker in tumorDOI 10.21203/rs.3.rs-3212266/v1Read

Genomic drivers of large B-cell lymphoma resistance to CD19 CAR-T therapySemantic proximity Read

Immunotherapeutic Value of Transcription Factor 19 (TCF19) Associated with Renal Clear Cell Carcinoma: A Comprehensive Analysis of 33 Human Cancer CasesSemantic proximity Read

Future perspectives on novel CAR-T therapeutics beyond CD19 and BCMA in onco-hematologySemantic proximity Read

Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphomaSemantic proximity Read

CD99 is a potential diagnostic and immunological biomarker in pan-cancerSemantic proximity Read

First generation anti-CD19 chimeric antigen receptor-modified T cells for management of B cell malignances: initial analysis of an ongoing Phase I clinical trialSemantic proximity Read

Bioinformatics investigation of the prognostic value and mechanistic role of CD9 in glioma.Semantic proximity Read

Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapySemantic proximity Read

Enhanced functionality of low-affinity CD19 CAR T-cells is associated with activation priming and a polyfunctional cytokine phenotypeSemantic proximity Read

The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progressionSemantic proximity Read

Toward targeting B cell cancers with CD4+ CTLs: identification of a CD19-encoded minor histocompatibility antigen using a novel genome-wide analysis.Semantic proximity Read

A c-Myc and Surface CD19 Signaling Amplification Loop Promotes B Cell Lymphoma Development and Progression in MiceSemantic proximity Read